- Active not recruitingPHASE3
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy
This study is testing a new medicine, tinlarebant, for a serious eye condition called Geographic Atrophy (GA). Researchers want to see if it's safe and helps improve or slow down GA. It's a key step in finding new treatments.
For: Geographic AtrophyUnited States · Australia · China - Active not recruitingPHASE2, PHASE3
A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease
This study is looking into a new medicine called Tinlarebant for young people aged 12-20 with an eye condition called Stargardt disease. It aims to see if the medicine is safe, if people can take it without too many problems, and if it helps improve their eyesight or slow the disease.
For: STGD1 · Stargardt Disease 1United States · Japan · United Kingdom